Case Report

The Voice of Copper: Wilson’s Disease Presenting with Progressive Dysarthria and Cirrhosis

DOI https://doi.org/10.70302/jpsim.v7i4.2671
Received: 15 Apr 2026 Revised: 18 Aug 2026 Accepted: 28 Oct 2026 Published Online: 20 Nov 2026

Abstract

Wilson’s disease (WD) is a rare autosomal recessive disorder of copper metabolism arising from pathogenic variants in the ATP7B gene. The resulting impairment in biliary copper excretion leads to progressive copper deposition in the liver, brain, cornea, and other organs, producing a heterogeneous clinical syndrome encompassing hepatic, neurological, psychiatric, and ophthalmological features. We report a 25-year-old male who presented with a one-year history of progressive dysarthria and abdominal distension. Clinical evaluation revealed bilateral Kayser–Fleischer rings, markedly reduced serum ceruloplasmin (5 mg/dL), elevated 24-hour urinary copper excretion (328.3 μg/24 h), biochemical evidence of chronic liver disease, and characteristic T2 hyperintensities of the basal ganglia, thalami, and midbrain on brain MRI. The Leipzig scoring system yielded a score of 8, establishing a definitive diagnosis of WD.This case highlights the importance of maintaining a high index of suspicion for Wilson’s disease in young patients presenting with concurrent neurological and hepatic manifestations. Early application of structured diagnostic criteria and prompt initiation of anti-copper therapy are essential to preventing irreversible organ damage and improving long-term prognosis.

Keywords:
Wilson’s disease dysarthria Kayser–Fleischer rings copper metabolism

How to Cite This Article

Batool M, Babar F, Irfan MB, Akram I, Sheikh MT, Imran M. The Voice of Copper: Wilson’s Disease Presenting with Progressive Dysarthria and Cirrhosis. J Pak Soc Intern Med. 2026;7(4):355–358. doi:10.70302/jpsim.v7i4.2671

⭳ Download XML (JATS)

Conflict of Interest

None

Disclosed in accordance with ICMJE and COPE guidelines.

Funding

None

Funder information follows the Crossref Funder Registry standard.

Author Contributions

MB: Conception.
FB, MBI: Design of the work.
IA, MTS, MI: Data acquisition, analysis, or interpretation.
MB, FB, IA, MTS, MI: Draft the work.
MBI: Review critically for important intellectual content.
All authors approve the version to be published.
All authors agree to be accountable for all aspects of the work.

Contributions are recorded against the ICMJE criteria for authorship.

Patient Consent

Informed consent for publication of clinical details was obtained from the patient.

References

  1. Jones J, Sharma R, Silverstone L. Wilson’s disease. Radiopaedia.org. 2026;https://doi.org/10.53347/rID-5380 doi:10.53347/rID-5380
  2. Immergluck J, Grant LM, Anilkumar AC. Wilson Disease. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2026; PMID: 28723019.
  3. Sandahl TD, Laursen TL, Munk DE, Vilstrup H, Weiss KH, Ott P. The prevalence of Wilson’s disease: an update. Hepatol. 2020;71(2):722–32. doi:10.1002/hep. 30911. doi:10.1002/hep
  4. Pop TL, Grama A. New developments in the management of Wilson’s disease in children. Global Pediatrics. 2024;doi:10.1016/j.gpeds.2024.100142. doi:10.1016/j.gpeds.2024.100142
  5. European Association for the Study of the Liver; European Reference Network on Rare Liver Diseases. EASL-ERN Clinical Practice Guidelines on Wilson’s disease. J Hepatol. 2025;doi:10.1016/j.jhep.2024.11.006. doi:10.1016/j.jhep.2024.11.006
  6. Dev S, Kruse RL, Hamilton JP, Lutsenko S. Wilson disease: update on pathophysiology and treatment. Front Cell Dev Biol. 2022;doi:10.3389/fcell.2022.871877. doi:10.3389/fcell.2022.871877
  7. Weiss KH, Stremmel W, Gotthardt DN, Klemm D, et al. Efficacy and safety of oral chelators in treatment of patients with Wilson disease. Clin Gastroenterol Hepatol. 2013;11(8):1028-35.
  8. Hawsawi YM. Novel variants associated with Wilson disease in Saudi families. J Gastroenterol Hepatol Res. 2019;8(10):1-8.
  9. Khan I, Iftikhar M, Khan SJ. Clinical and demographic profile of Wilson disease in young adults: a retrospective study at a tertiary care centre in Peshawar, Pakistan. Cureus. 2026;18(1):e100661.
  10. Kathawala M, Hirschfield GM. Insights into the management of Wilson’s disease. Ther Adv Gastroenterol. 2017;10(11):889–905.

Reference list indexed for Google Scholar and ResearchGate. DOI links resolve via doi.org.

CC BY CC BY 4.0 This article is published under the Creative Commons Attribution 4.0 International License. May be shared and adapted with attribution. Authors retain copyright. © 2026 The Author(s).